Corporate & Investor Presentation
Digital health solutions for inhaled COPD and asthma
pharmaceuticals
ResMed has end-to-end digital health solutions for COPD patients
across stages I, II, III, IV of the disease
•
Uses sensors with inhalers and consumer app to track medication
usage and provide insights to patients and physicians
Contracts with pharma companies to
support clinical trials and biologics
UPSTREAM
Customers include:
gsk
$$
Patients + $$
.
Establishes ResMed as a leading provider of COPD and
asthma patient management solutions
Enables digital integration through the continuum of care
and progression of the disease
Health and economic
outcomes
Direct and value-based contracts with
health systems and payers
Payers
DOWNSTREAM
Anthem
U
NOVARTIS
ORION
Increased drug
adherence and sales
Propeller
Improved clinical trial
speed and enhanced time
to market
49 2022 ResMed | Corporate & Investor Presentation - updated 27JAN22
PBMs
EXPRESS SCRIPTS
Clinical insights and
efficiencies
Health
systems
Dignity Health.
Pharmacies
$$
Patients + $$
Walgreens
Patient Enrollment & Engagement
ResMedView entire presentation